Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[18F]fluorobenzoate and application to 18F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography

« PreviousNuclear Medicine and Biology
Volume 35, Issue 6 , Pages 725-731, August 2008

Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[¹⁸F]fluorobenzoate and application to ¹⁸F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography

Peter Johnström
- Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
- Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
John C. Clark
- Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
John D. Pickard
- Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
Anthony P. Davenport
- Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
- Corresponding author. Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Box 110, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK. Tel.: +44 1223 336899; fax: +44 1223 762576.